expect in-lin revenu slight ep initi ep guidanc modestli st strong cro book
histor perform last yr ep qs average move flattish
lh quick take sometim time life everyth unfortun lh decid print one best quarter
time right midst elev market volatil hope peopl time appreci point today
manag nearli deliv everi metric possibl term revenu strength broad base strong core
volum growth nearli sizeabl beat cvd highlight contribut appear forecast well
organ turn margin om better forecast out-performance across divis
move line interest expens nickel headwind tax modest benefit thu ep
beat oper natur move manag notabl exceed fy target impress convers
addit cvd impress book momentum continu build prior check broadli confirm
acceler lastli guidanc revenu came notabl better bunch move part chang account
ep appear line gross tax benefit although would argu better fear post pama all-in tour de
forc lh manag like one best servic print expect share rel outperform
although direct market today anyon guess
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
organ lab volum growth came total volum growth end due
revenue/req rose
gross margin bp y-o-i larg drop ebita margin
segment basi dx saw bp y-o-i improv om cvd om rose bp y-o-
covanc book-to-bil net order bn ttm basi improv sequenti
lh revenu guidanc assum net revenu growth constant fx includ
impact new standard
labcorp diagnost expect grow includ pama bp fx constant fx growth
covanc revenu guidanc larg chiltern bp fx benefit
free cash flow quarter mm impli convers
pama implement headwind inclus increment color acla lawsuit potenti repriev
core revenu profit growth cro chang pace underli demand synergi captur launchpad
organ volum contributor dx includ mix market growth vs share gain well perform recent
view capit alloc prioriti post tax reform proport expect save like drop vs
valuat methodolog base mix discount cash flow analysi rel valuat multipl
downsid risk potenti pama relat price cut bleed commerci price ultim lead neg
margin cycl recent vertic integr hc servic organ lead increas price pressur given heighten focu
unit cost challeng associ integr small outreach lab deal could depress return invest capit prove
distract effort off-set pama cut increas cost save could yield servic challeng ultim depress core
organ volum poor perform major clinic trial could harm cvd reput lead signific shift cro
relat market share signific down-tick biotech relat fund could lead materi growth downshift earli phase
articl articl
time dissemin februari et
analyst ross muken elizabeth anderson suzi yoon primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view
report approv and/or distribut evercor group llc evercor group licens broker-deal regul
industri regulatori author finra intern strategi invest group uk limit isi uk authoris regul
unit kingdom financi conduct author institut sale trade research busi evercor group isi
uk collect oper global market brand name evercor isi evercor isi evercor group isi uk subsidiari
evercor partner inc evercor partner trademark logo servic mark shown report regist trademark
analyst associ respons prepar report receiv compens base variou factor includ evercor partner
total revenu portion gener affili invest bank transact evercor isi seek updat research
appropri variou regul may prevent happen certain instanc asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgment
evercor isi gener prohibit analyst associ member household maintain financi interest secur
compani analyst area coverag except polici requir specif approv member complianc
depart ownership subject complianc applic regul disclosur evercor isi also prohibit analyst associ
member household serv offic director advisori board member employe compani analyst
report may includ tactic call describ near-term event catalyst affect subject compani market overal
expect short-term price impact equiti share subject compani tactic call separ analyst
long-term recommend outperform under-perform reflect stock forward expect return formal rate
may differ target price recommend reflect analyst long-term view
applic current disclosur regard subject compani cover report avail offic evercor isi
obtain write evercor group llc attn complianc fifth avenu floor new york ny
evercor partner affili respect director offic member employe may interest
qualifi hold issuer mention report evercor partner affili may busi relationship
compani mention report
addit inform secur financi instrument mention report avail upon request
evercor isi recommend base stock total forecast return next month total forecast return equal
expect percentag price return plu gross dividend yield divid stock coverag three primari rate categori
outperform total forecast return expect greater expect total return analyst coverag univers
total forecast return expect line expect total return analyst univers
under-perform total forecast return expect less expect total return analyst univers
coverag suspend rate target price remov pursuant evercor isi polici evercor act advisori
capac merger strateg transact involv compani certain circumst
rate suspend evercor isi suspend rate target price stock suffici fundament basi
determin legal regulatori polici constraint around publish rate target price previou rate target price
longer effect compani reli upon
prior octob coverag suspend rate suspend categori includ categori suspend
finra requir member use rate system term buy hold/neutr sell equat
rate categori purpos evercor isi rate distribut outperform
under-perform rate equat buy hold sell respect
prior march evercor isi recommend base stock total forecast return next month
buy total forecast return expect greater
hold total forecast return expect greater equal less equal
sell total forecast return expect less
octob evercor partner acquir intern strategi invest group llc isi group isi uk acquisit
transfer evercor group research sale trade busi isi group decemb combin research sale
trade busi transfer back evercor group intern reorgan sinc acquisit combin research sale
trade busi oper global market brand name evercor isi
isi group isi uk
prior octob rate system isi group llc isi uk base risk adjust total return
buy return
neutral return
cautiou return
disclosur purpos isi group isi uk rate view follow strong buy buy equat buy neutral equat hold
